New diabetes clinical trial: Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets

Published on: April 16, 2025 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Empagliflozin + Linagliptin film-coated tablets; Drug: Glyxambi film-coated tablets
Sponsors: Humanis Saglık Anonim Sirketi
Completed
https://ift.tt/fWtTwqa